| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
|
Nature
|
2006
|
11.81
|
|
2
|
Energy-dependent regulation of cell structure by AMP-activated protein kinase.
|
Nature
|
2007
|
3.71
|
|
3
|
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.
|
J Clin Endocrinol Metab
|
2006
|
1.86
|
|
4
|
Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
|
Circ Res
|
2009
|
1.75
|
|
5
|
Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.
|
Diabetes
|
2012
|
1.62
|
|
6
|
Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.
|
J Clin Endocrinol Metab
|
2006
|
1.43
|
|
7
|
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
|
Diabetes
|
2009
|
1.31
|
|
8
|
Orphan nuclear receptor small heterodimer partner represses hepatocyte nuclear factor 3/Foxa transactivation via inhibition of its DNA binding.
|
Mol Endocrinol
|
2004
|
1.30
|
|
9
|
CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle.
|
J Biol Chem
|
2003
|
1.22
|
|
10
|
CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane.
|
Cell Metab
|
2012
|
1.17
|
|
11
|
Crif1 is a novel transcriptional coactivator of STAT3.
|
EMBO J
|
2008
|
1.16
|
|
12
|
CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
|
J Clin Endocrinol Metab
|
2003
|
1.12
|
|
13
|
Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
|
J Clin Endocrinol Metab
|
2012
|
1.09
|
|
14
|
Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
|
J Biol Chem
|
2003
|
1.07
|
|
15
|
Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.
|
J Clin Endocrinol Metab
|
2010
|
1.07
|
|
16
|
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
|
Mol Endocrinol
|
2003
|
1.06
|
|
17
|
Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner.
|
Hepatology
|
2009
|
1.06
|
|
18
|
Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death.
|
Cancer Res
|
2009
|
1.05
|
|
19
|
The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
|
Mol Endocrinol
|
2004
|
1.04
|
|
20
|
Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.
|
J Biol Chem
|
2009
|
1.02
|
|
21
|
Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2/neuroD.
|
Mol Endocrinol
|
2004
|
1.01
|
|
22
|
Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor-beta signaling by repressing SMAD3 transactivation.
|
J Biol Chem
|
2006
|
1.01
|
|
23
|
Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
|
Am J Physiol Endocrinol Metab
|
2008
|
1.00
|
|
24
|
Clinical characteristics of primary thyroid lymphoma in Koreans.
|
Endocr J
|
2009
|
0.98
|
|
25
|
Regulation of OPA1-mediated mitochondrial fusion by leucine zipper/EF-hand-containing transmembrane protein-1 plays a role in apoptosis.
|
Cell Signal
|
2009
|
0.98
|
|
26
|
CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation.
|
Mol Endocrinol
|
2004
|
0.98
|
|
27
|
Diagnostic value of pyrosequencing for the BRAF V600E mutation in ultrasound-guided fine-needle aspiration biopsy samples of thyroid incidentalomas.
|
Clin Endocrinol (Oxf)
|
2008
|
0.97
|
|
28
|
Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
|
J Immunol
|
2003
|
0.95
|
|
29
|
Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice.
|
PLoS Genet
|
2013
|
0.95
|
|
30
|
Differential role of the loop region between helices H6 and H7 within the orphan nuclear receptors small heterodimer partner and DAX-1.
|
Mol Endocrinol
|
2004
|
0.95
|
|
31
|
Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases.
|
Mol Endocrinol
|
2005
|
0.94
|
|
32
|
Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma.
|
PLoS One
|
2011
|
0.93
|
|
33
|
Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation.
|
Biochem J
|
2008
|
0.93
|
|
34
|
Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC.
|
BMC Cancer
|
2008
|
0.92
|
|
35
|
CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
|
Mol Endocrinol
|
2007
|
0.92
|
|
36
|
Prevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidase.
|
Free Radic Biol Med
|
2011
|
0.90
|
|
37
|
Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells.
|
Exp Mol Med
|
2002
|
0.90
|
|
38
|
Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
|
Am J Clin Oncol
|
2007
|
0.89
|
|
39
|
Anti-inflammatory roles of retinoic acid in rat brain astrocytes: Suppression of interferon-gamma-induced JAK/STAT phosphorylation.
|
Biochem Biophys Res Commun
|
2005
|
0.88
|
|
40
|
Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
|
Clin Cancer Res
|
2012
|
0.88
|
|
41
|
Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity.
|
Cardiovasc Res
|
2011
|
0.88
|
|
42
|
Pyrosequencing cut-off value identifying BRAFV600E mutation in fine needle aspiration samples of thyroid nodules.
|
Clin Endocrinol (Oxf)
|
2011
|
0.87
|
|
43
|
Bone mineral density in prediabetic men.
|
Korean Diabetes J
|
2010
|
0.87
|
|
44
|
RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
|
Mol Endocrinol
|
2003
|
0.86
|
|
45
|
DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly.
|
PLoS One
|
2012
|
0.86
|
|
46
|
Dual specificity phosphatase 6 as a predictor of invasiveness in papillary thyroid cancer.
|
Eur J Endocrinol
|
2012
|
0.86
|
|
47
|
Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
|
Mol Endocrinol
|
2007
|
0.84
|
|
48
|
Metformin inhibits growth hormone-mediated hepatic PDK4 gene expression through induction of orphan nuclear receptor small heterodimer partner.
|
Diabetes
|
2012
|
0.84
|
|
49
|
DJ-1 mediates paraquat-induced dopaminergic neuronal cell death.
|
Toxicol Lett
|
2011
|
0.83
|
|
50
|
Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
|
Int J Cancer
|
2008
|
0.83
|
|
51
|
IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter.
|
FASEB J
|
2013
|
0.82
|
|
52
|
Overexpression of ERp29 in the thyrocytes of FRTL-5 cells.
|
Mol Biol Rep
|
2005
|
0.82
|
|
53
|
Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
|
Mol Endocrinol
|
2004
|
0.82
|
|
54
|
EID-1 interacts with orphan nuclear receptor SF-1 and represses its transactivation.
|
Mol Cells
|
2007
|
0.82
|
|
55
|
Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage.
|
Neurobiol Aging
|
2009
|
0.82
|
|
56
|
The expression and role of serum response factor in papillary carcinoma of the thyroid.
|
Int J Oncol
|
2009
|
0.82
|
|
57
|
Differential immune response of adipocytes to virulent and attenuated Mycobacterium tuberculosis.
|
Microbes Infect
|
2011
|
0.81
|
|
58
|
Mitochondrial oxidative phosphorylation reserve is required for hormone- and PPARγ agonist-induced adipogenesis.
|
Mol Cells
|
2013
|
0.80
|
|
59
|
The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
|
Liver Int
|
2015
|
0.80
|
|
60
|
Reversible severe tricuspid regurgitation with right heart failure associated with thyrotoxicosis.
|
Thyroid
|
2006
|
0.80
|
|
61
|
Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans.
|
Endocrinology
|
2015
|
0.79
|
|
62
|
Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity.
|
Toxicol Lett
|
2013
|
0.79
|
|
63
|
An indole derivative protects against acetaminophen-induced liver injury by directly binding to N-acetyl-p-benzoquinone imine in mice.
|
Antioxid Redox Signal
|
2012
|
0.78
|
|
64
|
Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis.
|
J Clin Endocrinol Metab
|
2003
|
0.78
|
|
65
|
Increased vulnerability to β-cell destruction and diabetes in mice lacking NAD(P)H:quinone oxidoreductase 1.
|
Toxicol Lett
|
2013
|
0.78
|
|
66
|
Anti-obesity agents: a focused review on the structural classification of therapeutic entities.
|
Curr Top Med Chem
|
2009
|
0.78
|
|
67
|
Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells.
|
Cell Oncol (Dordr)
|
2011
|
0.77
|
|
68
|
Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
|
J Med Chem
|
2010
|
0.76
|
|
69
|
Disruption of CR6-interacting factor-1 (CRIF1) in mouse islet beta cells leads to mitochondrial diabetes with progressive beta cell failure.
|
Diabetologia
|
2015
|
0.76
|
|
70
|
The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
|
Int J Biochem Cell Biol
|
2013
|
0.76
|
|
71
|
NQO1 activation regulates angiotensin-converting enzyme shedding in spontaneously hypertensive rats.
|
Cardiovasc Res
|
2013
|
0.75
|
|
72
|
Epigenetic regulation of RUNX3 in thyroid carcinoma.
|
Korean J Intern Med
|
2012
|
0.75
|
|
73
|
Regulation of inhibitors of differentiation family proteins by thyroid-stimulating hormone in FRTL-5 thyroid cells.
|
J Korean Med Sci
|
2008
|
0.75
|